Dr Torres Viera speaks with ecancer at EHA 23 about suggested guidelines for lymphoma treatment in Venezuela, and how these differ from broader global practice.

She highlights the barriers to accessing PET-CT scans informing treatment reduction, late diagnosis of advanced disease and delaying radiotherapy and chemo treatment among reasons to recontextualise guidelines to more appropriate care.

Dr Torres Viera also notes the limited access to transplant centres, and trials which have confirmed efficacy from shorter courses of treatment with novel agents and combined therapies as other factors influencing Venezuelan lymphoma care.